Webinar: Pathogen Surveillance for Emergent Epidemics - POCTRN

null Webinar: Pathogen Surveillance for Emergent Epidemics

Webinar: Pathogen Surveillance for Emergent Epidemics

The response to Covid-19 and preventing future pandemics has brought an intense focus on the collection, aggregation and analysis of large data sets. Linking genomes with vaccine status, clinical data with consumer and mobility data, wastewater-based epidemiology with internet searches--the list is long and evolving. The integration of these data have both improved basic scientific understanding of epidemiology and also informed public health decision making during the pandemic. However, the use of data from communities and individuals to guide public health decisions has raised challenges throughout history and across pandemics--from HIV to tuberculosis to Ebola. The future use of "big data" to predict and contain outbreaks is no exception, and raises yet more issues which must be addressed for global early warning systems to be a reality. In this talk, I will discuss how the Rockefeller Foundation's Pandemic Prevention Institute is building a collaborative, global network that will ensure data are translated into public health action and pathogen containment.

Speaker

Samuel V. Scarpino, PhD
Managing Director, Pathogen Surveillance, The Rockefeller Foundation
External Faculty, Santa Fe Institute Vermont Complex Systems Center
Affiliate Assistant Professor, Northeastern University
Co-Founder, Global.health

When

February 22, 2022
2PM ET

Watch the webinar >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19